The NIH’s Top Vaccine Maker Wants Warp Speed To Be the New Normal

Are you concerned about the effect that use of the new vaccines will have on ongoing and future trials? I think the ethics of keeping trials going even when a vaccine is available are probably getting worked out now. But what about simply losing potential volunteers because they’re already getting other shots?

That issue will become front and center in the next few weeks. And I think it is a good problem to have. We have a vaccine that’s more effective than we even hoped for. And that means that we now have these ethical issues to address. How long can you really continue a placebo-controlled study, when you have good evidence that your vaccine works?

So what do I consider good evidence? Not a press release from a company, but the FDA looking at the data and saying, “Yes, we agree you have 95 percent efficacy, because we’ve looked

Read More